Remdesivir improves time to recovery in COVID-19 patients: Study

New York, May 27 () Remdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of care given to COVID-19 patients, according to a new study.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gsN2Yb
via IFTTT